Flunixin Meglumine API Manufacturer & Supplier

What is Flunixin Meglumine API?

Flunixin Meglumine (CAS No. 42461-84-7) is a non-steroidal anti-inflammatory drug (NSAID) formulated specifically for veterinary use, prepared as the meglumine salt of flunixin to improve solubility and absorption. Pharmacologically it acts as a cyclooxygenase (COX) inhibitor, reducing the production of prostaglandins responsible for pain, inflammation and fever. It is used across several livestock species — most prominently horses, cattle and swine — for conditions including colic and musculoskeletal pain in horses and acute inflammatory conditions such as mastitis in cattle. Marketed under trade names including Banamine, it is typically administered by injection for rapid onset, though oral presentations also exist.

As a food-producing-animal API it carries strict residue and documentation expectations, so veterinary formulators need a source with a controlled impurity profile and dossier-ready paperwork. Apex Pharma API manufactures and supplies the API itself, not the finished veterinary product.

Flunixin Meglumine API manufacturing at Apex Pharma API

We have manufactured Flunixin Meglumine in-house since 2015 at our Saykha GIDC plant in Bharuch, on an established route that keeps the impurity profile consistent between campaigns. Production runs in a 4 KL stainless-steel reactor, so we supply from evaluation samples through to repeat commercial volumes. This is our sole veterinary product; our other APIs serve human pharmaceutical formulation. Our complete product range and general sourcing process are covered on our API manufacturing page.

Applications and uses

Flunixin Meglumine API is formulated into veterinary medicines used to manage pain, inflammation and fever across several livestock species. In horses it is commonly associated with the treatment of colic and musculoskeletal conditions; in cattle it is used for acute inflammatory conditions including mastitis and respiratory disease; in swine it addresses similar inflammatory and febrile conditions. Its rapid onset when administered by injection makes it a preferred choice in acute veterinary care. This is general pharmacological context for buyer understanding, not a claim about the specific finished products manufactured by our customers.

Industries and customers we serve

Flunixin Meglumine API from Apex Pharma API is supplied to veterinary pharmaceutical formulation manufacturers producing injectable and oral animal-health products, and to distributors serving the veterinary segment. This is a distinct buyer category from the human pharmaceutical formulators we serve for our other products, and veterinary dossier documentation is prepared in-house for animal-health filings. Our full buyer-segment breakdown is on the API manufacturing companies in India page.

Why choose Apex Pharma API for Flunixin Meglumine API

• GMP- and GLP-certified manufacturing (Gujarat FDCA), with an ISO 9001:2015 quality management system and MSME ZED Bronze certification.
• Manufactured in-house since 2015 at our Saykha GIDC plant in Bharuch, in a 4 KL stainless-steel reactor, so the impurity profile stays consistent campaign to campaign.
• Batch-wise Certificate of Analysis issued as standard, with MSDS, specification sheet and method of analysis available, and veterinary dossier documentation on request.
• Manufacturer pricing, quoted directly — you buy from the plant that makes it, with evaluation samples and a batch CoA available before a bulk order.